The Molecular and Translational Allergology group at the Luxembourg Institute of Health (LIH) has reached a significant milestone, with two of its recent publications selected for inclusion in a prestigious review published in Allergy — one of the leading journals in the field.
A Major Step Forward in Allergy Research
The two studies were featured in the comprehensive review “Hot Topics in Allergen Immunotherapy, 2023: Current Status and Future Perspectives”, which highlights the latest advances in allergen immunotherapy and outlines key directions for future research.
Mapping Immune Responses in Real Time
One of the study’s most notable contributions focuses on the use of clustering algorithms to identify predictive biomarkers for peanut allergy. Led by Dr Annette Kuehn, the paper “High-Dimensional Immune Profiles Correlate with Phenotypes of Peanut Allergy During Food-Allergic Reactions” (DOI: 10.1111/all.15408) is the first to describe in real time the immune responses occurring during allergic food reactions.
This innovative approach provides a high-resolution view of immune cell populations and their dynamic changes during diagnostic oral food challenges. It offers valuable insights into inflammatory processes and holds promise for safer, more effective monitoring of therapeutic interventions such as oral immunotherapy.
“We consider this a great achievement,” said Dr Kuehn. “The inclusion of two LIH publications in such a prestigious review reflects the quality and relevance of our team’s contributions to the field.”
Updating the Molecular Allergology Roadmap
In the context of the constantly evolving landscape of allergens and their clinical significance, Dr Christiane Hilger co-led a publication bringing together a total of 100 authors from around the world. Working alongside Professor Markus Ollert and Dr Kuehn, Dr Hilger played a key role in delivering an updated overview of recognised allergen molecules and their clinical relevance.
The second edition of the EAACI Molecular Allergology User’s Guide (DOI: 10.1111/pai.13854) was highlighted in the review as an example of a comprehensive and up-to-date resource on allergen molecules and their role in allergy diagnosis and the prescription of allergen immunotherapy (AIT).
“These achievements not only provide valuable resources to the medical and scientific community, but also reflect our commitment to improving the lives of people affected by allergies,” said Dr Hilger.
LIH at the Forefront of Allergy Research
“LIH’s commitment to advancing allergy research is clearly demonstrated by these remarkable contributions, positioning the institute at the forefront of cutting-edge research in 2023,” concluded Professor Ollert.
